open access
Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology
Affiliations- Division of Gynecologic Endocrinology, Jagiellonian University Medical College, Cracow, Poland
- Corfamed Woman’s Health Center, Wroclaw, Poland
- Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, Poland
- 2nd Department of Gynecology and Obstetrics, Wroclaw Medical University, Wroclaw, Poland
open access
Abstract
The Polish Society of Gynecologists and Obstetricians and Polish Society of Colposcopy and Cervical Pathophysiology Interim Guidelines goal at aiding gynecologists in providing a cervical cancer prevention care during the evolving SARS-CoV-2 pan-demic. Presented guidelines were developed on a review of limited data and updated when new relevant publications were revealed. Timing for deferrals of diagnostic-therapeutic procedures were mostly covered in the guidelines. Also, a support for the existing Polish recommendations on abnormal screening results in a subject of minor and major screening abnor-malities terminology were given. The guidelines are obligatory for the specified COVID-19 pandemic period only and they might be changed depending on the new available evidence.
Abstract
The Polish Society of Gynecologists and Obstetricians and Polish Society of Colposcopy and Cervical Pathophysiology Interim Guidelines goal at aiding gynecologists in providing a cervical cancer prevention care during the evolving SARS-CoV-2 pan-demic. Presented guidelines were developed on a review of limited data and updated when new relevant publications were revealed. Timing for deferrals of diagnostic-therapeutic procedures were mostly covered in the guidelines. Also, a support for the existing Polish recommendations on abnormal screening results in a subject of minor and major screening abnor-malities terminology were given. The guidelines are obligatory for the specified COVID-19 pandemic period only and they might be changed depending on the new available evidence.
Keywords
cervical cancer prevention; abnormal screening results; HPV testing; cervical cytology; selfsampling; SARS-CoV-2 pandemic; guidelines
About this articleTitle
Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology
Journal
Issue
Article type
Guidelines / Expert consensus
Pages
428-431
Published online
2020-07-31
Page views
1403
Article views/downloads
1290
DOI
Pubmed
Bibliographic record
Ginekol Pol 2020;91(7):428-431.
Keywords
cervical cancer prevention
abnormal screening results
HPV testing
cervical cytology
selfsampling
SARS-CoV-2 pandemic
guidelines
Authors
Robert Jach
Maciej Mazurec
Martyna Trzeszcz
Mariusz Zimmer
References (13)- The World Health Organization. WHO Director-General's opening remarks on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (11 March 2020).
- Rozporządzenie Rady Ministrów z dnia 26 kwietnia 2020 r. zmieniające rozporządzenie w sprawie ustanowienia określonych ograniczeń, nakazów i zakazów w związku z wystąpieniem stanu epidemii. http://dziennikustaw gov pl/DU/2020/697 (Accessed 27 March 2020).
- The American Society for Colposcopy and Cervical Pathology. ASCCP Interim Guideline for Timing and Treatment Procedures for Patients with Abnormal Cervical Screening Tests. https://www.asccp.org//covid-19-resources (20 March 2020).
- Zalecenia dla kobiet w okresie okołoporodowym w związku z ogłoszonym na obszarze Rzeczypospolitej Polskiej stanem epidemii w związku z zakażeniami wirusem SARS-CoV-2. .https://www.gov.pl/web/zdrowie/zalecenia-dla-kobiet-w-okresie-okoloporodowym-w-zwiazku-z-zakazeniami-sars-cov-2 (20 March 2020).
- Rekomendowana ścieżka postępowania dla kobiet w ciąży COVID-19. https://www.ptgin.pl/rekomendowana-sciezka-postepowania-dla-kobiet-w-ciazy-covid-19 (21 March 2020).
- Józefiak A, Kędzia W, Kotarski J, et al. Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL). Ginekol Pol. 2013; 84: 395–399.
- National Cervical Cancer Screening Programme in Poland Coordinating Centre; Polish Gynaecological Society; Polish Society of Pathologists; Polish Society of Colposcopy and Uterine Cervix Pathology. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology. Ginekol Pol. 2009 Feb. ; 80(2): 129–38.
- Nasierowska-Guttmejer A, Kędzia W, Wojtylak S, et al. Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines. Ginekol Pol. 2016; 87(9): 670–676.
- Winer R, Lin J, Tiro J, et al. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment. JAMA Network Open. 2019; 2(11): e1914729.
- European Society for Medical Oncology. Management and Treatment Adapted Recommendations in the COVID-19 Era: Cervical Cancer. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/gynaecological-malignancies-cervical-cancer-in-the-covid-19-era (10 April 2020).
- Ramirez PT, Chiva L, Eriksson AG, et al. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020; 30(5): 561–563.
- SGS, SGO, ASRM, AAGL AUGS, IGCS, SFP, SRS. Joint Statement on Re-introduction of Hospital and Office-based Procedures in the COVID-19 Climate for the Practicing Urogynecologist and Gynecologist. https://www.sgo.org/wp-content/uploads/2020/04/Reintroduction-of-Hospital-and-Office-Procedures-in-the-COVID-19-Climate.pdf (April 2020).
- LeBrun EW, Moawad N, Rosenberg E, et al. Coronavirus disease 2019 pandemic: staged management of surgical services for gynecology and obstetrics. American Journal of Obstetrics and Gynecology. 2020; 223(1): 85.e1–85.e19.
